For example, a variety of options have showed efficiency for treating BED, including antidepressants, anticonvulsants, opioid receptor antagonists, and anti-obesity medicines, such as cannabinoid receptor 1 (CB1) antagonists and GLP-1 analogs [44]. This evidence concerns the gene CNR1 and X-linked cone dysfunction syndrome with myopia.